Ken Griffin
BDTX icon

Ken Griffin’s Black Diamond Therapeutics BDTX Stock Holding History

Ken Griffin’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.4K Buy
11,000
+100
+0.9% +$238 ﹤0.01% 12632
2025
Q4 		$26.5K Buy
+10,900
New +$38.6K ﹤0.01% 12266
2025
Q2 		– Sell
-22,100
Closed -$34.3K – 12572
2025
Q1 		$34.3K Buy
22,100
+19,200
+662% +$40.3K ﹤0.01% 12688
2024
Q4 		$6.21K Sell
2,900
-5,100
-64% -$14.6K ﹤0.01% 13809
2024
Q3 		$34.8K Buy
8,000
+7,600
+1,900% +$41.4K ﹤0.01% 12297
2024
Q2 		$1.86K Sell
400
-7,300
-95% -$39.2K ﹤0.01% 13767
2024
Q1 		$39K Buy
7,700
+5,100
+196% +$20.6K ﹤0.01% 12415
2023
Q4 		$7.31K Sell
2,600
-15,000
-85% -$35.2K ﹤0.01% 13293
2023
Q3 		$50.5K Sell
17,600
-92,600
-84% -$341K ﹤0.01% 11750
2023
Q2 		$557K Buy
110,200
+102,500
+1,331% +$209K ﹤0.01% 7712
2023
Q1 		$14.6K Sell
7,700
-7,300
-49% -$16.8K ﹤0.01% 13301
2022
Q4 		$27K Sell
15,000
-52,200
-78% -$94K ﹤0.01% 12869
2022
Q3 		$114K Buy
67,200
+27,800
+71% +$85.7K ﹤0.01% 10977
2022
Q2 		$97K Buy
+39,400
New +$91.6K ﹤0.01% 11435
2021
Q4 		– Sell
-18,100
Closed -$153K – 13798
2021
Q3 		$153K Sell
18,100
-10,600
-37% -$105K ﹤0.01% 12356
2021
Q2 		$350K Buy
+28,700
New +$567K ﹤0.01% 10889

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ken Griffin's BDTX Position: Q1 2026 in Review

Ken Griffin increased its Black Diamond Therapeutics (BDTX) stake by 18% in Q1 2026, buying an estimated $184K and bringing the position to 502,652 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #7500.

Ken Griffin first reported a position in BDTX in Q1 2021 and has held it in 18 quarters since. The position peaked at $6.14M in Q2 2023. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

  • Ken Griffin held 502,652 shares of Black Diamond Therapeutics worth $1.07M as of Q1 2026.
  • Ken Griffin bought 77,193 Black Diamond Therapeutics shares in Q1 2026, an estimated $184K.
  • Black Diamond Therapeutics made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #7500 holding.
  • Ken Griffin first reported a position in Black Diamond Therapeutics in Q1 2021 and has held it in 18 quarters since.
  • Ken Griffin's Black Diamond Therapeutics position peaked at $6.14M in Q2 2023.
  • 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.